Advancing delivery technologies for biologics and large molecules
The problem
Most animal health medicines are delivered systematically, leading to the need for larger doses, limited target range potential and off-target side effects
The solution
Pioneering the next generation of macromolecule delivery technologies to unlock the full therapeutic potential of biologics, oligonucleotides, and other large molecules